Gastric Acid Production: GERD, PUD, and Gastritis Explained
This paper examines the pathophysiology of gastric acid stimulation and production, focusing on the role of parietal cells, hormonal triggers such as gastrin, and the three phases of acid secretion. It explores how three common gastrointestinal conditions — gastroesophageal reflux disease (GERD), peptic ulcer disease (PUD), and gastritis — alter normal acid production and lead to clinical symptoms. The paper further considers how aging affects disease presentation and severity in each condition. Finally, it outlines diagnostic approaches and treatment options, including lifestyle modification, antacids, and surgical intervention where appropriate.
- Pathophysiology of Gastric Acid Stimulation and Production: Parietal cells, gastrin, and the three secretion phases
- How GERD, PUD, and Gastritis Affect Gastric Acid: Disease-specific disruptions to normal acid production
- How Age Affects the Pathophysiology of These Conditions: Aging increases vulnerability to all three conditions
- Diagnosis and Treatment of GERD, PUD, and Gastritis: Diagnostic tests and treatment options for each condition
- Conclusion: Excess gastric acid causes manageable but discomforting disorders
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper moves logically from basic physiology to specific diseases, then to aging effects, and finally to diagnosis and treatment — creating a clear clinical progression that mirrors how practitioners think about gastrointestinal conditions.
- Each disease (GERD, PUD, gastritis) is given a consistent treatment structure: definition, mechanism, and link to gastric acid, which makes comparison straightforward for readers.
- The aging section adds clinical relevance by explaining not just that older patients are more affected, but why — weakened muscles, damaged esophageal lining, and medication use.
Key academic technique demonstrated
The paper uses pathophysiological reasoning as its core analytical method — tracing how disruptions in the normal acid-production pathway produce specific disease states. Rather than simply listing symptoms, it explains the mechanistic links between cellular function, hormonal signaling, and clinical outcomes, demonstrating cause-and-effect thinking appropriate to health sciences writing.
Structure breakdown
The paper opens with foundational physiology (parietal cells, gastrin, the three secretion phases), then applies that foundation to three diseases in parallel. A dedicated section on aging follows, revisiting each disease through a geriatric lens. The final section pairs each disease with its diagnostic tests and first-line treatments before a brief synthesizing conclusion. Five peer-reviewed sources are cited in APA format throughout.
Pathophysiology of Gastric Acid Stimulation and Production
The parietal cells in the stomach are responsible for the production of gastric acid. Parietal cells contain secretory canaliculi, which produce gastric acid and release it into the gastric lumen. Gastric acid is produced in response to messages received through hormonal, paracrine, and neurocrine messengers (Schubert & Peura, 2008). The production of gastric acid undergoes three phases: the cephalic phase, the gastric phase, and the intestinal phase. Gastrin, the major hormonal trigger of gastric acid production, is produced by the G cells located in the pyloric mucosa of the stomach. The G cells release gastrin in response to a meal. However, Histamine 2 receptors are thought to be the primary stimulus for the secretion of gastric acid.
How GERD, PUD, and Gastritis Affect Gastric Acid
Gastroesophageal reflux disease (GERD) is a common digestive disorder caused by the reflux of acid from the stomach into the esophagus. GERD is more commonly referred to as heartburn. Hydrochloric acid is naturally produced in the human stomach, which signals the gastric gland to secrete gastric acid containing the essential digestive enzymes for breaking down protein molecules and enabling easy digestion (Kahrilas, 2003). There are instances when too much or too little acid is produced. Excess secretion of acid in the stomach causes acid reflux into the esophagus, resulting in heartburn. This condition leads to an increase in the stimulation and production of gastric acid in the stomach. Gastric acid is therefore a trigger for the symptoms of GERD. Dietary and lifestyle changes can reduce the amount of gastric acid produced in the stomach.
Peptic ulcer disease (PUD) refers to painful sores in the lining of the stomach or the duodenum. It mainly occurs due to a disturbance of mucosal integrity in the stomach caused by local inflammation, which eventually leads to a mucosal defect. Based on its pathophysiology, the disease can be either acute or chronic. The pathophysiology may include ulcers caused by anti-inflammatory drugs, excess acid secretion, or transmissible etiology. There is a heightened likelihood of developing PUD when a person experiences a massive secretion of gastric acid. Increased secretion of gastric acid most commonly occurs in people who have an elevated number of parietal cells.
Gastritis is the inflammation of the stomach's protective lining. Acute gastritis involves sudden, severe inflammation, while chronic gastritis includes long-term inflammation that can last for years if untreated. Gastritis is commonly caused by weaknesses in the stomach lining that allow digestive juices to inflame and damage it. There is an increase in the production of gastric acid in the stomach of a person suffering from gastritis because the stomach wall allows acid to pass through more easily. An abnormal increase in gastric secretion results in abdominal pain caused by increased acid activity within the stomach.
How Age Affects the Pathophysiology of These Conditions
Research has shown that GERD in infants and children is more common than previously thought, but it is most prevalent among the elderly. Elderly people may suffer from abnormal reflux of acid into the esophagus. Because elderly individuals have weakened muscles, they are more prone to GERD, meaning they may experience more frequent heartburn or a more severe form of the disease (Chait, 2010). A decrease in esophageal pain perception is often demonstrated in elderly patients, which can make it appear that they suffer less from GERD even when the condition is clinically significant. Older patients experience an increase in gastric acid production, which is no longer reliably triggered by meals alone. Acid reflux increases the amount of acid in both the stomach and the esophagus in elderly patients, who are also more likely to have sustained damage to the esophageal lining over time.
PUD is most likely to affect people over the age of 50. However, research has indicated that approximately 70% of those diagnosed with the disease are between 25 and 65 years of age. Therefore, while age is not the sole contributor to the pathophysiology of PUD, older individuals remain at higher risk. Anti-inflammatory drugs — commonly prescribed to elderly patients — can disrupt mucosal balance and lead to massive secretion of gastric acid, thereby causing or worsening PUD.
The destruction of the stomach lining is the primary driver of gastritis, and elderly persons are more likely to experience this deterioration. As a person ages, the stomach lining becomes weaker, making it easier for acid to penetrate the wall. An increase in gastric acid within the stomach accelerates the destruction of the stomach lining, resulting in chronic gastritis.
Conclusion
The stimulation and production of gastric acid within the stomach aids in the digestion of food, but excessive gastric acid results in abnormalities. These abnormalities can lead to different complications, including GERD, PUD, and gastritis. While the conditions are not typically life-threatening and can be effectively managed, they do affect quality of life by causing the patient significant discomfort and pain.
References
Boeckxstaens, G. E., & Rohof, W. O. (2014). Pathophysiology of gastroesophageal reflux disease. Gastroenterology Clinics of North America, 43(1), 15–25.
Chait, M. M. (2010). Gastroesophageal reflux disease: Important considerations for the older patient. World Journal of Gastrointestinal Endoscopy, 2(12), 388.
Kahrilas, P. J. (2003). GERD pathogenesis, pathophysiology, and clinical manifestations. Cleveland Clinic Journal of Medicine, 70(5), S4.
Konturek, P. C., & Konturek, S. J. (2014). Peptic ulcer disease. In Metabolism of Human Diseases (pp. 129–135). New York: Springer.
Schubert, M. L., & Peura, D. A. (2008). Control of gastric acid secretion in health and disease. Gastroenterology, 134(7), 1842–1860.
Create your account
Always verify citation format against your institution’s current style guide requirements.